Acelyrin Inc (SLRN)
4.385
-0.24
(-5.29%)
USD |
NASDAQ |
May 17, 16:00
4.385
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Lexicon Pharmaceuticals Inc | 94.56% |
Eagle Pharmaceuticals Inc | 93.70% |
Avalo Therapeutics Inc | 99.98% |
Design Therapeutics Inc | -- |
CEL-SCI Corp | 96.13% |